VP Immunology Data Sciences
Janssen R&D US
Why I'm a JPAL
Supporting DrugViu and companies at JLABS @ NYC.
Dr. Curran is Global Head of Data Sciences and core member of the Immunology therapeutic area leadership team. Mark has accumulated over 25 years of experience in drug development spanning biotech and big pharma. He is a Janssen veteran of ten-plus years and is currently leading the Immunology data science organization with responsibilities spanning data management and engineering to implementation of cutting edge real world evidence strategies. Prior positions include leading target discovery, biomarkers and diagnostics, and compound development teams at multiple companies and performing experimental medicine, Phase 1, and 2a/2b clinical trials for multiple compounds in immunology. Prior to joining big pharma, Mark gained valuable experience in biotech and venture capital working with start-up companies having focus on genetics, genomics, target discovery and validation, personalized medicine, companion diagnostics and early drug development. Mark earned his doctorate in Human Genetics at the University of Utah and BS/MS degrees in biology from Worcester Polytechnic Institute. He has co-authored over 60 peer reviewed scientific publications and holds multiple patents. He has contributed seminal discoveries in the field of predictive medicine, genetics of heritable cardiac arrhythmias and developed the Familion™ genetic diagnostic test for long QT syndrome. His primary interests are discovery of novel therapeutics with emphasis on early drug development, implementation of molecular diagnostics for personalized medicine and evolution of Data Sciences, Digital Health Care and Integrated Patient Care Solutions to improve the lives of all patients living with auto-immune disease.
"Whatever you do, get good data"
- Raymond White
I was a semi-professional ten pin bowler